Literature DB >> 20619724

Sensitive absorption-based wave-mixing detector for anthracycline drugs separated by capillary electrophoresis.

Sandrine Berniolles1, Hongjing Kan, William G Tong.   

Abstract

Sensitive absorption-based detection of anthracycline antibiotics, daunorubicin and doxorubicin is demonstrated using a capillary electrophoresis system interfaced to a nonlinear wave-mixing detection system. Unlike conventional absorption methods, this nonlinear absorption method can detect very thin analytes (50 microm) efficiently. At the same peak height, the wave-mixing CE peak is narrower than a conventional CE peak, and hence, compared to other laser-based or non-laser-based CE on-column detection methods, our wave-mixing detection method offers intrinsically enhanced separation resolution even when using identical CE separation conditions. In this unusually sensitive "absorbance" detection method, two input laser beams interact to produce a thermally induced grating from which coherent laser-like wave-mixing signal beams are created. Using our sensitive "absorbance" on-column CE detector, we report a preliminary concentration detection limit of 9.9x10(-10)M using a 50-mum i.d. capillary column. The corresponding "injected" mass detection limit is 9.1x10(-18)mol using an injection volume of 9.2nL. The corresponding preliminary "detected" mass detection limit inside the 12-pL detector probe volume is 1.2x10(-20)M. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619724      PMCID: PMC2914113          DOI: 10.1016/j.saa.2010.05.007

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  13 in total

1.  Sub-parts-per-quadrillion-level graphite furnace atomic absorption spectrophotometry based on laser wave mixing.

Authors:  Fritz K Mickadeit; Sandrine Berniolles; Helen R Kemp; William G Tong
Journal:  Anal Chem       Date:  2004-03-15       Impact factor: 6.986

Review 2.  Chromatographic analysis of anticancer drugs.

Authors:  U R Tjaden; E A de Bruijn
Journal:  J Chromatogr       Date:  1990-10-12

3.  Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography.

Authors:  R Hulhoven; J P Desager
Journal:  J Chromatogr       Date:  1976-09-29

4.  New high-performance liquid chromatographic assay for plasma doxorubicin.

Authors:  A N Kotake; N J Vogelzang; R A Larson; N Choporis
Journal:  J Chromatogr       Date:  1985-01-11

5.  Forward-scattering degenerate four-wave mixing as a simple sub-attomole-sensitive nonlinear laser analytical spectrometric method.

Authors:  Z Wu; W G Tong
Journal:  Anal Chem       Date:  1993-01-15       Impact factor: 6.986

6.  Sensitive circular dichroism spectroscopy based on nonlinear degenerate four-wave mixing.

Authors:  J A Nunes; W G Tong
Journal:  Anal Chem       Date:  1993-11-01       Impact factor: 6.986

7.  Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumor.

Authors:  N Siméon; E Chatelut; P Canal; M Nertz; F Couderc
Journal:  J Chromatogr A       Date:  1999-08-20       Impact factor: 4.759

8.  Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatography.

Authors:  P A Maessen; K B Mross; H M Pinedo; W J van der Vijgh
Journal:  J Chromatogr       Date:  1987-07-03

9.  Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis.

Authors:  Nina Griese; Gottfried Blaschke; Joachim Boos; Georg Hempel
Journal:  J Chromatogr A       Date:  2002-12-06       Impact factor: 4.759

10.  CE-LIF method for the separation of anthracyclines: application to protein binding analysis in plasma using ultrafiltration.

Authors:  Gillian Whitaker; Amy Lillquist; Stephanie A Pasas; Robert O'Connor; Fiona Regan; Craig E Lunte; Malcolm R Smyth
Journal:  J Sep Sci       Date:  2008-06       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.